The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Open accessAbstract
Drug delivery technology has a wide spectrum, which is continuously being upgraded at a stupendous speed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SLNs, characterized by a solid lipid core stabilized with surfactants, provide high stability, reproducibility, and scalability, whereas NLCs, incorporating both solid and liquid lipids, improve drug loading, stability, and release control [29].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SLNs, characterized by a solid lipid core stabilized with surfactants, provide high stability, reproducibility, and scalability, whereas NLCs, incorporating both solid and liquid lipids, improve drug loading, stability, and release control [29].”
From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,836
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,158
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,116
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt‐Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,458
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. D. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,224
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. S. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,001
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
Mühlen, A. Z., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar200019c · Cited by 906
Freitas, C., & Müller, R. H. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00092-1 · Cited by 690
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles
Li, H., Zhao, X. B., Ma, Y., Zhai, G., Li, L., & Lou, H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.002 · Cited by 666
Research works printed but not linked: 19
- M. J.Mycek , R. A.Harvey and P. C.Champe , Pharmacology , Lippincott Williams & Wilkins , Philadelphia, P.A. , 2000
- Scheffel, 1970, J. Nucl. Med., 13, 498
- Gohla, 2001, Pharmazie, 56, 61
- R.Kammari , N. G.Das and S. K.Das , Emerging Nanotechnologies for Diagnostics , Drug Delivery and Medical Devices Micro and Nano Technologies , 2017 , pp. 105–144
- Mehnert, 2001, Adv. Drug Deliv. Rev., 47, 165, 10.1016/S0169-409X(01)00105-3 · DOI
- Freitas, 1999, Eur. J. Pharm. Biopharm., 47, 125, 10.1016/S0939-6411(98)00074-5 · DOI
- Dianzani, 2014, BioMed Res. Int., 895
- Jenning, 2000, Eur. J. Pharm. Biopharm., 49, 211, 10.1016/S0939-6411(99)00075-2 · DOI
- Wissing, 2001, Adv. Drug Delivery Rev., 23, 233
- Wissing, 2001, J. Cosmet. Sci., 52, 313
- Waghmare, 2012, Int. Res. J. Pharm., 3, 100
- Svilenov, 2014, Nanomedicine, 187
- Chen, 2006, China J. Chin. Mater. Med., 31, 376
- Siekmann, 1992, Pharm. Pharmacol. Lett., 1, 123
- Cavalli, 1998, Pharmazie, 53, 392
- Jain, 2013, Drug Deliv., 373
- Liu, 2007, Int. J. Pharm., 328, 191, 10.1016/j.ijpharm.2006.08.007 · DOI
- Wissing, 2003, Int. J. Pharm., 254, 65, 10.1016/S0378-5173(02)00684-1 · DOI
- Mehnert, 2001, Adv. Drug Deliv. Rev., 47, 165, 10.1016/S0169-409X(01)00105-3 · DOI
Cited by
Sorted by citations
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y. A., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 776
Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 551
Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review
Khan, M. I., Hossain, I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00002 · Cited by 388
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 377
Metadata
- Authors
- Duan, Y., Dhar, A., Patel, C., Khimani, M., Neogi, S., Sharma, P., Siva Kumar, N., & Vekariya, R. L.
- Affiliations
- Zhengzhou University (CN)
- Jadavpur University (IN)
- P P Savani University (IN)
- Department of Chemical Engineering
- Ton Duc Thang University (VN)
- Corresponding author
- Vekariya, Rohit L.
- ORCID
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 10
- Issue
- 45
- Pages
- 26777-26791
- ISSN
- 2046-2069 (ISSN-L)
- PMC
- PMC9055574
- OpenAlex
- W3043255293
- Cited by
- 614
- References
- 118
- Citations by year
- 2026: 68 · 2025: 119 · 2024: 139 · 2023: 126 · 2022: 98 · 2021: 58 · 2020: 6
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- RSC Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81903623)
- China Postdoctoral Science Foundation (2019M652586)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- solid lipid nanoparticles, nanostructured lipid carriers, drug delivery systems, poorly water-soluble drugs, pharmacokinetics, liposomes, ethosomes, virosomes, deformable liposomes, surfactants, lipid excipients, nanoparticle stability, storage, theranostics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
